About Theralase - Cold Laser Manufacturer
Theralase Technologies Inc. designs, develops and manufactures super-pulsed, cold laser technology for a wide range of human, companion animal and equine applications. Bio-stimulative capabilities include: healing neural muscular skeletal conditions through pain elimination, inflammation reduction and increased tissue regeneration. Combining Theralase laser technology with photodynamic compounds (PDCs) leads to bio-destructive capabilities, including destruction of cancer cells, bacteria, viruses and fat cells. Theralase lasers penetrate deeper - up to 10 cm (4 in) below the skin surface - and heal tissue faster than any other cold laser on the market. Theralase customers benefit from access to continuous advancements, as well as support and training from highly trained professionals.
In addition to the development and provision of laser technology, Theralase operates a full service medical rehabilitation clinic in Toronto, Ontario for training and education of health-care practitioners.
Theralase study points to cancer breakthrough
Photodynamic therapy (PDT) is a potential treatment regime for a number of conditions. It involves introducing particular light-sensitive chemical species into biological systems, inducing them to localize at the point of interest, and then irradiating them with a light source.
It holds particular promise as a treatment to combat certain cancers, and the latest results from trials using a system developed by Ontario-based Theralase have shown that PDT was able to completely destroy subcutaneous colon cancer tumors in a mouse model. Four weeks after treatment, the mice remained free of cancer.